Whether you’re trying to coax a toddler into taking cough medicine or puzzling out how best to introduce a large-molecule biologic, each drug delivery scenario presents unique challenges. Teams developing the drug must work hand-in-hand with teams developing the delivery device, ultimately agreeing on the proper combination of elements to best serve the intended patient pool — a process that weaves together decisions concerning biocompatibility, container size and shape, delivery mechanism, human factors engineering, and countless other elements. In this eBook, our editors have assembled insights from some of the experts in this field among our editorial contributors.
Herman F. Bozenhardt of Bozenhardt Consulting Services and Erich H. Bozenhardt of Integrated Project Services kick off the eBook with a deep dive into liposomes as a drug delivery platform, from engineering to production. Then, Barbara Berglund of CMC Turnkey Solutions explores the key considerations involved in choosing a CMO to produce your nanotechnology-based drug delivery system. Charles L. Mauro of Mauro Usability Science follows with a look at the importance of human factors engineering relevant to drug delivery device design. AstraZeneca’s Michael Song wraps up the eBook with a trio of articles: one looking at general considerations for drug delivery device design, and the final two comprising a comprehensive look at prefilled syringe selection.
Thank you for taking the time to read, and please reach out to let us know topics you’d like to see covered in the future!